Corina Borza
Faculty Member
Last active: 11/9/2017


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Quantitative Structure-Activity Relationship Modeling of Kinase Selectivity Profiles. Kothiwale S, Borza C, Pozzi A, Meiler J (2017) Molecules 22(9)
    › Primary publication · 28925954 (PubMed) · PMC6151389 (PubMed Central)
  2. Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis. Borza CM, Su Y, Tran TL, Yu L, Steyns N, Temple KJ, Skwark MJ, Meiler J, Lindsley CW, Hicks BR, Leitinger B, Zent R, Pozzi A (2017) Matrix Biol : 258-271
    › Primary publication · 27915093 (PubMed) · PMC5329129 (PubMed Central)
  3. Cell Receptor-Basement Membrane Interactions in Health and Disease: A Kidney-Centric View. Borza CM, Chen X, Zent R, Pozzi A (2015) Curr Top Membr : 231-53
    › Primary publication · 26610916 (PubMed) · PMC4913201 (PubMed Central)
  4. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery. Kothiwale S, Borza CM, Lowe EW, Pozzi A, Meiler J (2015) Drug Discov Today 20(2): 255-61
    › Primary publication · 25284748 (PubMed) · PMC4336622 (PubMed Central)
  5. Discoidin domain receptors in disease. Borza CM, Pozzi A (2014) Matrix Biol : 185-92
    › Primary publication · 24361528 (PubMed) · PMC4019715 (PubMed Central)
  6. Inhibition of integrin α2β1 ameliorates glomerular injury. Borza CM, Su Y, Chen X, Yu L, Mont S, Chetyrkin S, Voziyan P, Hudson BG, Billings PC, Jo H, Bennett JS, Degrado WF, Eckes B, Zent R, Pozzi A (2012) J Am Soc Nephrol 23(6): 1027-38
    › Primary publication · 22440900 (PubMed) · PMC3358756 (PubMed Central)
  7. The role of cell-extracellular matrix interactions in glomerular injury. Borza CM, Pozzi A (2012) Exp Cell Res 318(9): 1001-10
    › Primary publication · 22417893 (PubMed) · PMC3770307 (PubMed Central)
  8. Integrin {alpha}1{beta}1 promotes caveolin-1 dephosphorylation by activating T cell protein-tyrosine phosphatase. Borza CM, Chen X, Mathew S, Mont S, Sanders CR, Zent R, Pozzi A (2010) J Biol Chem 285(51): 40114-24
    › Primary publication · 20940300 (PubMed) · PMC3000994 (PubMed Central)
  9. Integrin alpha1beta1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor gamma-dependent caveolin-1 expression. Chen X, Whiting C, Borza C, Hu W, Mont S, Bulus N, Zhang MZ, Harris RC, Zent R, Pozzi A (2010) Mol Cell Biol 30(12): 3048-58
    › Primary publication · 20368353 (PubMed) · PMC2876688 (PubMed Central)
  10. Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions. Pozzi A, Zent R, Chetyrkin S, Borza C, Bulus N, Chuang P, Chen D, Hudson B, Voziyan P (2009) J Am Soc Nephrol 20(10): 2119-25
    › Primary publication · 19608705 (PubMed) · PMC2754111 (PubMed Central)
  11. Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer. Macias-Perez I, Borza C, Chen X, Yan X, Ibanez R, Mernaugh G, Matrisian LM, Zent R, Pozzi A (2008) Cancer Res 68(15): 6127-35
    › Primary publication · 18676835 (PubMed) · PMC2801028 (PubMed Central)
  12. Functional analysis of the cytoplasmic domain of the integrin {alpha}1 subunit in endothelial cells. Abair TD, Bulus N, Borza C, Sundaramoorthy M, Zent R, Pozzi A (2008) Blood 112(8): 3242-54
    › Primary publication · 18647959 (PubMed) · PMC2569176 (PubMed Central)
  13. Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. Borza CM, Borza DB, Pedchenko V, Saleem MA, Mathieson PW, Sado Y, Hudson HM, Pozzi A, Saus J, Abrahamson DR, Zent R, Hudson BG (2008) J Am Soc Nephrol 19(4): 677-84
    › Primary publication · 18235087 (PubMed) · PMC2390958 (PubMed Central)
  14. Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. Borza CM, Pozzi A, Borza DB, Pedchenko V, Hellmark T, Hudson BG, Zent R (2006) J Biol Chem 281(30): 20932-20939
    › Primary publication · 16731529 (PubMed)
  15. Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells. Wu L, Borza CM, Hutt-Fletcher LM (2005) J Virol 79(17): 10923-30
    › Primary publication · 16103144 (PubMed) · PMC1193614 (PubMed Central)
  16. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. Borza CM, Morgan AJ, Turk SM, Hutt-Fletcher LM (2004) J Virol 78(10): 5007-14
    › Primary publication · 15113881 (PubMed) · PMC400351 (PubMed Central)
  17. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Borza CM, Hutt-Fletcher LM (2002) Nat Med 8(6): 594-9
    › Primary publication · 12042810 (PubMed)
  18. EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT (2001) Curr Top Microbiol Immunol : 153-60
    › Primary publication · 11443860 (PubMed)
  19. Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. Molesworth SJ, Lake CM, Borza CM, Turk SM, Hutt-Fletcher LM (2000) J Virol 74(14): 6324-32
    › Primary publication · 10864642 (PubMed) · PMC112138 (PubMed Central)
  20. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT (1999) Mol Cell Biol 19(3): 1651-60
    › Primary publication · 10022853 (PubMed) · PMC83959 (PubMed Central)
  21. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells. Borza CM, Hutt-Fletcher LM (1998) J Virol 72(9): 7577-82
    › Primary publication · 9696856 (PubMed) · PMC110006 (PubMed Central)
  22. Role of heme-hemopexin in human T-lymphocyte proliferation. Smith A, Eskew JD, Borza CM, Pendrak M, Hunt RC (1997) Exp Cell Res 232(2): 246-54
    › Primary publication · 9168799 (PubMed)
  23. Histones of Chlamydomonas reinhardtii. Synthesis, acetylation, and methylation. Waterborg JH, Robertson AJ, Tatar DL, Borza CM, Davie JR (1995) Plant Physiol 109(2): 393-407
    › Primary publication · 7480339 (PubMed) · PMC157602 (PubMed Central)